Every winter, Austin gets walloped by cedar fever: runny noses, scratchy throats, watering eyes, and canceled plans as ...
A confirmed Phase 3 trial success and a robust financial position are setting the stage for Xencor, Inc. to potentially redefine its market standing. Despite these strengths, the company's equity ...
The CEO of ModeX Therapeutics discusses MDX2003, a groundbreaking tetraspecific therapy that promises enhanced efficacy and ...
News-Medical.Net on MSN
Aston Sci. Inc. implements CDD Vault to support AI-driven cancer vaccine development
Aston Sci. Inc., a clinical-stage biopharmaceutical company pioneering next-generation therapeutic cancer vaccines, announced ...
Newco Tecregen AG has raised CHF10 million (US$12.5 million) to advance a novel way of regenerating the thymus in order to boost T-cell production and stimulate recovery of the immune system following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback